Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Breast Disease|February 3, 2005
Antagonists of tumor-specific immunity: tumor-induced immune suppression and host genes that co-opt the anti-tumor immune responseSuzanne Ostrand-Rosenberg, Pratima Sinha, Erika A Danna, et al.Cancer Research|October 19, 2007
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progressionStephanie K Bunt, Linglin Yang, Pratima Sinha, et al.Blood|April 1, 2011
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLPratima Sinha, Olesya Chornoguz, Virginia K Clements, et al.Cancer Immunology, Immunotherapy : CII|November 1, 2003
Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic diseaseSuzanne Ostrand-Rosenberg, Pratima Sinha, Virginia Clements, et al.Cancer Research|March 18, 2004
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic diseaseErika A Danna, Pratima Sinha, Mileka Gilbert, et al.Journal of Leukocyte Biology|December 24, 2016
Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in miceSuzanne Ostrand-Rosenberg, Pratima Sinha, Chas Figley, et al.Journal of Leukocyte Biology|August 30, 2014
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumorsDaniel W Beury, Katherine H Parker, Maeva Nyandjo, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Mouse lysozyme-M knockout mice reveal how the self-determinant hierarchy shapes the T cell repertoire against this circulating self antigen in wild-type micePratima Sinha, Howard H Chi, Hong R Kim, et al.Cancer Research|August 29, 2014
HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cellsKatherine H Parker, Pratima Sinha, Lucas A Horn, et al.Oncotarget|September 24, 2017
CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1+ tumor cells, and extends the survival of tumor-bearing humanized miceLucas A Horn, Nicholas G Ciavattone, Ryan Atkinson, et al.Pageof 5